Peptide-directed HPMA copolymer-doxorubicin conjugates as targeted therapeutics for colorectal cancer

References

• Ahlskog J, Paganelli G, Neri D. (2006). Vascular tumor targeting. Q J Nucl Med Mol Imaging, 50, 296–309.
   PubMed Web of Science ®Google Scholar
• Allen TM. (2002). Ligand-targeted therapeutics in anticancer therapy. Nat Rev Cancer, 2, 750–763.
   PubMed Web of Science ®Google Scholar
• Barnard JA, Beauchamp RD, Russell WE, Dubois RN, Coffey RJ. (1995). Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology. Gastroenterology, 108, 564–580.
   PubMed Web of Science ®Google Scholar
• Bresalier RS, Mazurek N, Sternberg LR, Byrd JC, Yunker CK, Nangia-Makker P, Raz A. (1998). Metastasis of human colon cancer is altered by modifying expression of the beta-galactoside-binding protein galectin 3. Gastroenterology, 115, 287–296.
   PubMed Web of Science ®Google Scholar
• Ciardiello F, Kim N, Saeki T, Dono R, Persico MG, Plowman GD, Garrigues J, Radke S, Todaro GJ, Salomon DS. (1991). Differential expression of epidermal growth factor-related proteins in human colorectal tumors. Proc Natl Acad Sci USA, 88, 7792–7796.
   PubMed Web of Science ®Google Scholar
• Cohen S. (1983). The epidermal growth factor (EGF). Cancer, 51, 1787–1791.
   PubMed Web of Science ®Google Scholar
• Cunningham MP, Essapen S, Thomas H, Green M, Lovell DP, Topham C, Marks C, Modjtahedi H. (2006). Coexpression of the IGF-IR, EGFR and HER-2 is common in colorectal cancer patients. Int J Oncol, 28, 329–335.
   PubMed Web of Science ®Google Scholar
• David A. (2010). Carbohydrate-based biomedical oopolymers for targeted delivery of anticancer drugs. Isr J Chem, 50, 204–219.
   Web of Science ®Google Scholar
• David A, Kopecková P, Kopecek J, Rubinstein A. (2002). The role of galactose, lactose, and galactose valency in the biorecognition of N-(2-hydroxypropyl)methacrylamide copolymers by human colon adenocarcinoma cells. Pharm Res, 19, 1114–1122.
   PubMed Web of Science ®Google Scholar
• David A, Kopecková P, Minko T, Rubinstein A, Kopecek J. (2004). Design of a multivalent galactoside ligand for selective targeting of HPMA copolymer-doxorubicin conjugates to human colon cancer cells. Eur J Cancer, 40, 148–157.
   PubMed Web of Science ®Google Scholar
• David A, Kopecková P, Rubinstein A, Kopecek J. (2001). Enhanced biorecognition and internalization of HPMA copolymers containing multiple or multivalent carbohydrate side-chains by human hepatocarcinoma cells. Bioconjug Chem, 12, 890–899.
   PubMed Web of Science ®Google Scholar
• Drobník J, Kopeček J, Labský J, Rejmanová P, Exner J, Saudek V, Kálal J. (1976). Enzymatic cleavage of side chains of synthetic water-soluble polymers. Makromol Chem, 177, 2833–2848.
   Web of Science ®Google Scholar
• Goldstein NS, Armin M. (2001). Epidermal growth factor receptor immunohistochemical reactivity in patients with American Joint Committee on Cancer Stage IV colon adenocarcinoma: implications for a standardized scoring system. Cancer, 92, 1331–1346.
   PubMed Web of Science ®Google Scholar
• Hansen MB, Nielsen SE, Berg K. (1989). Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods, 119, 203–210.
   PubMed Web of Science ®Google Scholar
• Irimura T, Matsushita Y, Sutton RC, Carralero D, Ohannesian DW, Cleary KR, Ota DM, Nicolson GL, Lotan R. (1991). Increased content of an endogenous lactose-binding lectin in human colorectal carcinoma progressed to metastatic stages. Cancer Res, 51, 387–393.
   PubMed Web of Science ®Google Scholar
• Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. (2009). Cancer statistics, 2009. CA Cancer J Clin, 59, 225–249.
   PubMed Web of Science ®Google Scholar
• Kari C, Chan TO, Rocha de Quadros M, Rodeck U. (2003). Targeting the epidermal growth factor receptor in cancer: apoptosis takes center stage. Cancer Res, 63, 1–5.
   PubMed Web of Science ®Google Scholar
• Kopecek C, Bazilova H. (1973). Poly[N-(2-hydroxypropyl)methacrylamide] I. Radical polymerization and copolymerization. Eur Polym J, 9, 7–14.
   Web of Science ®Google Scholar
• Kopecek J, Kopecková P. (2010). HPMA copolymers: origins, early developments, present, and future. Adv Drug Deliv Rev, 62, 122–149.
   PubMed Web of Science ®Google Scholar
• Kumar SR, Deutscher SL. (2008). 111In-labeled galectin-3-targeting peptide as a SPECT agent for imaging breast tumors. J Nucl Med, 49, 796–803.
   PubMed Web of Science ®Google Scholar
• Lahm H, André S, Hoeflich A, Fischer JR, Sordat B, Kaltner H, Wolf E, Gabius HJ. (2001). Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures. J Cancer Res Clin Oncol, 127, 375–386.
   PubMed Web of Science ®Google Scholar
• Li Z, Zhao R, Wu X, Sun Y, Yao M, Li J, Xu Y, Gu J. (2005). Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics. FASEB J, 19, 1978–1985.
   PubMed Web of Science ®Google Scholar
• Lotan R, Matsushita Y, Ohannesian D, Carralero D, Ota DM, Cleary KR, Nicolson GL, Irimura T. (1991). Lactose-binding lectin expression in human colorectal carcinomas. Relation to tumor progression. Carbohydr Res, 213, 47–57.
   PubMed Web of Science ®Google Scholar
• Matsumura Y, Maeda H. (1986). A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res, 46, 6387–6392.
   PubMed Web of Science ®Google Scholar
• Messa C, Russo F, Caruso MG, Di Leo A. (1998). EGF, TGF-alpha, and EGF-R in human colorectal adenocarcinoma. Acta Oncol, 37, 285–289.
   PubMed Web of Science ®Google Scholar
• Nakahara S, Raz A. (2008). Biological modulation by lectins and their ligands in tumor progression and metastasis. Anticancer Agents Med Chem, 8, 22–36.
   PubMed Web of Science ®Google Scholar
• Omelyanenko V, Kopecková P, Gentry C, Kopecek J. (1998). Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate. J Control Release, 53, 25–37.
   PubMed Web of Science ®Google Scholar
• Pearson JR, Gill CI, Rowland IR. (2009). Diet, fecal water, and colon cancer–development of a biomarker. Nutr Rev, 67, 509–526.
   PubMed Web of Science ®Google Scholar
• Radinsky R, Risin S, Fan D, Dong Z, Bielenberg D, Bucana CD, Fidler IJ. (1995). Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells. Clin Cancer Res, 1, 19–31.
   PubMed Web of Science ®Google Scholar
• Rathi RC, Kopeckova P, Rıhova B, Kopecek J. (1991). N-(2-hydroxypropyl)methacrylamide copolymers containing pendant saccharide moieties: synthesis and bioadhesives properties. J Polym Sci, Part A: Polym Chem, 29, 1895–1902.
   Web of Science ®Google Scholar
• Rejmanova P, Labsky J, Kopecek J. (1977). Aminolyses of monomeric and polymeric 4-nitrophenyl esters of N-methacryloylated amino acids. Makromol Chem, 178, 2159–2168.
   Web of Science ®Google Scholar
• Ríhová B, Etrych T, Pechar M, Jelínková M, Stastný M, Hovorka O, Kovár M, Ulbrich K. (2001). Doxorubicin bound to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomes. J Control Release, 74, 225–232.
   PubMed Web of Science ®Google Scholar
• Schoeppner HL, Raz A, Ho SB, Bresalier RS. (1995). Expression of an endogenous galactose-binding lectin correlates with neoplastic progression in the colon. Cancer, 75, 2818–2826.
   PubMed Web of Science ®Google Scholar
• Shamay Y, Paulin D, Ashkenasy G, David A. (2009). E-selectin binding peptide-polymer-drug conjugates and their selective cytotoxicity against vascular endothelial cells. Biomaterials, 30, 6460–6468.
   PubMed Web of Science ®Google Scholar
• Song S, Liu D, Peng J, Sun Y, Li Z, Gu JR, Xu Y. (2008). Peptide ligand-mediated liposome distribution and targeting to EGFR expressing tumor in vivo. Int J Pharm, 363, 155–161.
   PubMed Web of Science ®Google Scholar
• van Oosten M, Crane LM, Bart J, van Leeuwen FW, van Dam GM. (2011). Selecting Potential Targetable Biomarkers for Imaging Purposes in Colorectal Cancer Using TArget Selection Criteria (TASC): A Novel Target Identification Tool. Transl Oncol, 4, 71–82.
   PubMed Web of Science ®Google Scholar
• Yarden Y, Sliwkowski MX. (2001). Untangling the ErbB signalling network. Nat Rev Mol Cell Biol, 2, 127–137.
   PubMed Web of Science ®Google Scholar
• Zou J, Glinsky VV, Landon LA, Matthews L, Deutscher SL. (2005). Peptides specific to the galectin-3 carbohydrate recognition domain inhibit metastasis-associated cancer cell adhesion. Carcinogenesis, 26, 309–318.
   PubMed Web of Science ®Google Scholar